Similar articles for PMID: 12557126

Year	Number of Results
1989	2
1990	1
1991	6
1992	2
1993	7
1994	3
1995	5
1996	3
1997	5
1998	5
1999	5
2000	4
2001	6
2002	7
2003	3
2004	4
2005	2
2006	4
2007	9
2008	9
2009	5
2010	9
2011	4
2012	4
2013	2
2014	2
2015	1
2018	3
2021	1
2024	0

1

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. Barcellos LF, et al. Am J Hum Genet. 2003 Mar;72(3):710-6. doi: 10.1086/367781. Epub 2003 Jan 28. Am J Hum Genet. 2003. PMID: 12557126 Free PMC article.

2

Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.

Haegert DG, Swift FV, Benedikz J. Haegert DG, et al. Neurology. 1996 Apr;46(4):1107-11. doi: 10.1212/wnl.46.4.1107. Neurology. 1996. PMID: 8780100

3

Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis.

Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Serjeantson SW, et al. Eur J Immunogenet. 1992 Feb-Apr;19(1-2):11-9. doi: 10.1111/j.1744-313x.1992.tb00043.x. Eur J Immunogenet. 1992. PMID: 1567812

4

Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.

Zipp F, Windemuth C, Pankow H, Dichgans J, Wienker T, Martin R, Müller C. Zipp F, et al. Hum Immunol. 2000 Oct;61(10):1021-30. doi: 10.1016/s0198-8859(00)00173-7. Hum Immunol. 2000. PMID: 11082515

5

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis.

Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A. Celius EG, et al. J Neurol Sci. 2000 Sep 15;178(2):132-5. doi: 10.1016/s0022-510x(00)00389-0. J Neurol Sci. 2000. PMID: 11018705

6

Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.

Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, Palmer JP, Lernmark A. Sanjeevi CB, et al. Tissue Antigens. 1994 Aug;44(2):110-9. doi: 10.1111/j.1399-0039.1994.tb02366.x. Tissue Antigens. 1994. PMID: 7817375

7

Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

González-Enríquez GV, Torres-Mendoza BM, Márquez-Pedroza J, Macías-Islas MA, Ortiz GG, Cruz-Ramos JA. González-Enríquez GV, et al. Immunogenetics. 2018 Aug;70(8):547-551. doi: 10.1007/s00251-018-1052-8. Epub 2018 Feb 3. Immunogenetics. 2018. PMID: 29397401

8

HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.

Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, Ghaderi A. Amirzargar A, et al. Eur J Immunogenet. 1998 Aug;25(4):297-301. doi: 10.1046/j.1365-2370.1998.00101.x. Eur J Immunogenet. 1998. PMID: 9777330

9

The Dai minority population of southwest China: heterogeneity of DR2-associated HLA-DRB1,DRB5,DQA1, and DQB1 haplotypes.

Fan L, Chandanayingyong D, Smith AG, Hansen JA. Fan L, et al. Hum Immunol. 1996 Feb;45(2):143-7. doi: 10.1016/0198-8859(95)00149-2. Hum Immunol. 1996. PMID: 8882413

10

DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.

Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. Marrosu MG, et al. Hum Mol Genet. 1998 Aug;7(8):1235-7. doi: 10.1093/hmg/7.8.1235. Hum Mol Genet. 1998. PMID: 9668164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year